GORE® PROPATEN® Vascular Graft
- Home / GORE® PROPATEN® Vascular Graft / News /
Gore Receives CE Mark for GORE® PROPATEN® Vascular Graft for Hemodialysis Access
22 February 2011 - Unique Vascular Graft Transcends Mechanical Solutions for Dialysis Access
22 February 2011 - Unique Vascular Graft Transcends Mechanical Solutions for Dialysis Access
New Clinical Evidence Supporting Efficacy of GORE® PROPATEN® Vascular Graft
19 January 2011 - Jes Lindholt, MD, PhD presented new study data from a Scandinavian clinical trial designed to compare patency rates of the GORE PROPATEN Vascular Graft with standard ePTFE grafts (GORE-TEX® Stretch Vascular Graft).
19 January 2011 - Jes Lindholt, MD, PhD presented new study data from a Scandinavian clinical trial designed to compare patency rates of the GORE PROPATEN Vascular Graft with standard ePTFE grafts (GORE-TEX® Stretch Vascular Graft).
New Study Data Shows Advantages of GORE® PROPATEN® Vascular Grafts Compared with Standard ePTFE Grafts at One Year
12 October 2010 - Randomized, Multi-center Data Presented at the European Society for Vascular Surgery (ESVS) Annual Meeting Compares Luminal Heparin Bonded ePTFE Vascular Grafts to Standard ePTFE Vascular Grafts
12 October 2010 - Randomized, Multi-center Data Presented at the European Society for Vascular Surgery (ESVS) Annual Meeting Compares Luminal Heparin Bonded ePTFE Vascular Grafts to Standard ePTFE Vascular Grafts
Gore Expands Line of GORE PROPATEN® Vascular Grafts
21 December 2009 - Integrated radial support offers all the benefits of a ringed graft while the GORE PROPATEN Bioactive Surface helps to improve thromboresistance and patency.
21 December 2009 - Integrated radial support offers all the benefits of a ringed graft while the GORE PROPATEN Bioactive Surface helps to improve thromboresistance and patency.
Vascular Surgeons Present Positive Study Results for the GORE PROPATEN® Vascular Graft and Updates to the GORE VIABAHN® Endoprosthesis
21 September 2009 - Physicians report new information at the Society for Vascular Surgery's annual meeting
21 September 2009 - Physicians report new information at the Society for Vascular Surgery's annual meeting
Vascular Surgeons Present Positive Study Results for the GORE PROPATEN® Vascular Graft and Updates to the GORE VIABAHN® Endoprosthesis
17 September 2009 - Physicians report new information at the Society for Vascular Surgery's annual meeting
17 September 2009 - Physicians report new information at the Society for Vascular Surgery's annual meeting
Vascular Surgeons Present Positive Study Results for the GORE PROPATEN® Vascular Graft and Updates to the GORE VIABAHN® Endoprosthesis
18 March 2009 - Multi-center, multi-year, worldwide data presented adds to the growing body of evidence for ePTFE Heparin Vascular Graft
18 March 2009 - Multi-center, multi-year, worldwide data presented adds to the growing body of evidence for ePTFE Heparin Vascular Graft
W. L. Gore & Associates Presents New Data and Clinical Updates at Transcatheter Cardiovascular Therapeutics (TCT) Conference 2008
08 October 2008 - Gore continues commitment to clinical research with symposia, ongoing clinical studies and emerging technologies
08 October 2008 - Gore continues commitment to clinical research with symposia, ongoing clinical studies and emerging technologies
W. L. Gore & Associates Announces Positive Interim Study Results for GORE PROPATEN Vascular Graft
22 July 2008 - Interim and pivotal data presented at Society of Vascular Surgery's Annual Meeting
22 July 2008 - Interim and pivotal data presented at Society of Vascular Surgery's Annual Meeting
Gore Announces First Patient Enrolled in PRODIGY Study
24 March 2008 - Post-market study to compare performance of GORE PROPATEN Vascular Graft todisadvantaged autologous vein graft in below-knee peripheral arterial disease bypasses.
24 March 2008 - Post-market study to compare performance of GORE PROPATEN Vascular Graft todisadvantaged autologous vein graft in below-knee peripheral arterial disease bypasses.